4437 studies found for:    Open Studies | "Immune System"
Show Display Options
Rank Status Study
21 Recruiting Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk (10-0188, Pfizer)
Conditions: Non-alcoholic Fatty Liver Disease;   Metabolic Syndrome
Intervention:
22 Recruiting The Effect of AGE on the Immune System
Condition: Healthy
Interventions: Dietary Supplement: Aged Garlic Extract Supplementation Group;   Other: Standard for Groups;   Dietary Supplement: Placebo
23 Recruiting Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)
Conditions: Cystic Fibrosis;   Respiratory Tract Infections
Intervention: Dietary Supplement: Cholecalciferol
24 Not yet recruiting Cord Milking and Activity Of The Immune System In Preterm Infants
Condition: Preterm Delivery
Intervention: Other: CORD MILKING
25 Unknown  The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
Condition: Maternal-fetal Transmission of Cytomegalovirus During Pregnancy
Intervention:
26 Recruiting Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
Conditions: T-cell Lymphoma;   B-Cell Lymphoma;   ATL;   Myeloma
Intervention:
27 Recruiting Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer
Condition: Breast Cancer
Intervention:
28 Unknown  A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Conditions: HIV Infection;   Gastrointestinal Symptoms
Interventions: Dietary Supplement: GanedenBC30, GBI-30, PTA-6086;   Drug: Placebo
29 Recruiting Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol
Condition: Healthy Volunteers
Intervention:
30 Unknown  The Effect of Physical Activity on Bone Mineralization and Immune System in Very Low Birth Weight Infants
Condition: Osteopenia of Prematurity
Intervention: Behavioral: passive physical activity
31 Recruiting The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
Condition: Melanoma
Intervention: Drug: Vemurafenib
32 Recruiting Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
Condition: Leukemia
Intervention: Other: blood samples
33 Recruiting Immune System Related Kidney Disease
Conditions: Glomerulonephritis;   Lupus Nephritis;   Membranous Glomerulonephritis;   Autoimmune Disease;   Nephrotic Syndrome
Intervention:
34 Unknown  Manipulation of Visceral Sensitivity and Immune System in IBS
Condition: Irritable Bowel Syndrome
Intervention: Drug: probiotic (bacterial/dietary supplement)
35 Recruiting Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Multiple;   Mycosis Fungoides;   Hodgkin's Lymphoma;   Multiple Myeloma
Intervention: Drug: Dasatinib
36 Recruiting Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma
Conditions: Mantle Cell Lymphoma;   Diffuse Large Cell Lymphoma;   Burkitts Lymphoma;   T Cell Lymphomas;   Acute Myeloid Leukemia/Acute Lymphoblastic Leukemia
Intervention: Biological: cellular immunotherapy
37 Recruiting Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Conditions: Myelodysplastic Syndrome;   Hodgkin's Lymphoma;   Non-Hodgkin's Disease;   Acute Leukemia;   Multiple Myeloma
Interventions: Biological: Rituximab;   Drug: Cyclosporine;   Drug: Allogenic stem cell transplant (ASCT);   Drug: Conditioning Chemotherapy;   Drug: TMS;   Drug: FLAG;   Drug: EPOCH-F;   Biological: Alemtuzumab
38 Recruiting The Immune System's Response to Young Women's Breast Cancer
Conditions: Breast Cancer;   Breast Cancer and Pregnancy
Intervention:
39 Unknown  How Our Immune System Can Help Fight Cancer
Condition: Ovarian Cancer
Intervention:
40 Unknown  Study of Ipilimumab in the Immune System
Condition: Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
Intervention: Drug: Ipilimumab at 10 mg/kg dose

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years